1
Martinelli, T.F., Vander Laenen, F., Nagelhout, G.E., van de Mheen, D.H.
Veröffentlicht in: Martinelli , T F , Vander Laenen , F , Nagelhout , G E & van de Mheen , D H 2022 , ' Addiction and Recovery in Dutch Governmental and Practice-Level Drug Policy: What's the Problem Represented to be? ' , Journal of Drug Issues , vol. 52 , no. 4 , 00220426221087590 , pp. 547-567 . https://doi.org/10.1177/00220426221087590;
2022
Veröffentlicht in: Martinelli , T F , Vander Laenen , F , Nagelhout , G E & van de Mheen , D H 2022 , ' Addiction and Recovery in Dutch Governmental and Practice-Level Drug Policy: What's the Problem Represented to be? ' , Journal of Drug Issues , vol. 52 , no. 4 , 00220426221087590 , pp. 547-567 . https://doi.org/10.1177/00220426221087590;
2022
2
Bruijn, Larissa Michelle, Vols, Michel, Brouwer, Jan G.
Veröffentlicht in: Bruijn , L M , Vols , M & Brouwer , J G 2018 , ' Home closure as a weapon in the Dutch war on drugs : Does judicial review function as a safety net? ' , International Journal of Drug Policy , vol. 51 , pp. 137-147 . https://doi.org/10.1016/j.drugpo.2017.08.003;
2018
Veröffentlicht in: Bruijn , L M , Vols , M & Brouwer , J G 2018 , ' Home closure as a weapon in the Dutch war on drugs : Does judicial review function as a safety net? ' , International Journal of Drug Policy , vol. 51 , pp. 137-147 . https://doi.org/10.1016/j.drugpo.2017.08.003;
2018
3
Martinelli, Thomas F., Vander Laenen, Freya, Nagelhout, Gera E., van de Mheen, Dike H.
Veröffentlicht in: Martinelli , T F , Vander Laenen , F , Nagelhout , G E & van de Mheen , D H 2022 , ' Addiction and recovery in Dutch governmental and practice-level drug policy : What's the problem represented to be? ' , Journal of Drug Issues , vol. 52 , no. 4 , pp. 547-567 . https://doi.org/10.1177/00220426221087590;
2022
Veröffentlicht in: Martinelli , T F , Vander Laenen , F , Nagelhout , G E & van de Mheen , D H 2022 , ' Addiction and recovery in Dutch governmental and practice-level drug policy : What's the problem represented to be? ' , Journal of Drug Issues , vol. 52 , no. 4 , pp. 547-567 . https://doi.org/10.1177/00220426221087590;
2022
4
5
6
7
8
9
10